Trial Profile
Outcome in Hemodialysis of Promus stent
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms OUCH-PRO
- 11 Nov 2011 New trial record